Müller, R.-U., Lianne Messchendorp, A., Birn, H., Capasso, G., Cornec-Le Gall, E., Devuyst, O., Eerde, A. van, Guirchoun, P., Harris, T., Hoorn, E.J., Knoers, N.V., Korst, U., Mekahli, D., Le Meur, Y., Nijenhuis, T., Ong, A.C., Sayer, J.A., Schaefer, F., Servais, A., Tesar, V., Torra, R. and Gansevoort, S.B.W. and R.T. 2022. An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. KIDNEYS. 11, 1 (May 2022), 37–39. DOI:https://doi.org/10.22141/2307-1257.11.1.2022.357.